Clinical trial
Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of…
NCT00226746 · New York Presbyterian Brooklyn Methodist Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00226746 |
|---|---|
| Title | Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer |
| Official title | A Multicenter Phase II Trial of Weekly Gemcitabine, Paclitaxel, and Hyperfractionated External Irradiation (63.80 GY) for Locally Advanced Pancreatic Cancer |
| Lead sponsor | New York Presbyterian Brooklyn Methodist Hospital, Other |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Pancreatic Ductal |
| Intervention type | Drug |
| Interventions | Paclitaxel and gemcitabine |
| Enrollment | 0 |
| Start date | Mar 1, 2003 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2012 |
| First posted | Sep 27, 2005 |
| Last update posted | Sep 18, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: